Study in Adults to Assess the Safety and Efficacy of Inhaled IBIO123, for Post-exposure Prophylaxis of COVID-19
Clinical trial NCT05639166 · COMPLETED
Trial details
- NCT number
- NCT05639166
- Sponsor
- Immune Biosolutions Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-18
- Primary completion
- 2023-05-16
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.